🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an observational study to assess the tolerability of Rebif treatmen...
Status
Completed
Location
Samsung Medical Center
Start Date
2008-08
Trial ID
NCT01074346
Treatments Being Tested
The present study is a randomized clinical trial, with the approval of the ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-20
Trial ID
NCT04521400
Treatments Being Tested
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i....
Status
Active Not Recruiting
Location
UAB Childrens Hospital Harbor Center Neurology Dept
Start Date
2013-07-26
Trial ID
NCT01892722
Treatments Being Tested
The main objectives of Part 1 are as follows: To evaluate the safety, toler...
Status
Completed
Location
Boston Children's Hospital
Start Date
2014-08-28
Trial ID
NCT02283853
Treatments Being Tested
The purpose of this study is to determine whether ozanimod is effective in ...
Status
Completed
Location
Xenosciences Inc
Start Date
2014-12-03
Trial ID
NCT02294058
Treatments Being Tested
Primary objective was to assess the effectiveness evaluated by the time to ...
Status
Completed
Location
Investigational Site Number 056003
Start Date
2009-04
Trial ID
NCT00883337
Treatments Being Tested
The primary objective of this study is to investigate whether Peg-IFN beta-...
Status
Completed
Location
Research Site
Start Date
2016-02-03
Trial ID
NCT02587065
Treatments Being Tested
This study assessed the safety, tolerability, and efficacy of 2 doses of or...
Status
Completed
Location
North Central Neurology Associates, PC, 1809 Kress Street
Start Date
2006-05
Trial ID
NCT00340834
Treatments Being Tested
The primary objective of this study is to evaluate the long-term safety and...
Status
Completed
Location
Research Site
Start Date
2011-04
Trial ID
NCT01332019
Treatments Being Tested
To compare two commonly used MS medications, IFN β-1a subcutaneous three ti...
Status
Withdrawn
Location
Partners MS Center, 1 Brookline Place Suite 225
Start Date
2015-05
Trial ID
NCT02419638
Treatments Being Tested